Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness

Laboratory Investigation

Volumn 81, Issue 4, 2001, Pages 565-571

  Glöckner, Sabine ^a   Lehmann, Ulrich ^a   Wilke, Nadine ^a   Kleeberger, Wolfram ^a   Länger, Florian ^a   Kreipe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA TOPOISOMERASE (ATP HYDROLYSING); MYC PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; MOLECULAR BIOLOGY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; REGULATOR GENE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL NUCLEUS; DISEASE PROGRESSION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GROWTH SUBSTANCES; HUMANS; NEOPLASM INVASIVENESS;

EID: 0035053050     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780265     Document Type: Article

References (30)

1. Cyclin D1 in breast cancer
2. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast
3. Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer
4. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways
5. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
6. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups
7. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors
8. Relating genotype and phenotype in breast cancer: An analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations
9. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
10. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast
11. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ)
12. Real time quantitative PCR
13. Ductal carcinoma in situ: A proposal for a new classification
14. Amplification and deletion of topoisomerase llalpha associate with erbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer
15. Erbb2 amplification in breast cancer analyzed by fluorescence in situ hybridization
16. P53, ErbB2, and TAG-72 expression in the spectrum of ductal carcinoma in situ of the breast classified by the Van Nuys system
17. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
18. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer
19. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1
20. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization
21. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction
22. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast: Comparative genomic hybridization study of pure high-grade DCIS
23. Prognostic classification of breast ductal carcinoma-in-situ
24. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast
25. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology
26. Genetic aberrations in hypodiploid breast cancer: Frequent loss of chromosome 4 and amplification of cyclin D1 oncogene
27. Intraductal carcinoma
28. Ductal carcinoma in situ of the breast: Histological classification and genetic alterations
29. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast
30. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type